{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:58Z","timestamp":1794047518769,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2025.288939","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:08:44Z","timestamp":1761811724000},"page":"1478-1483","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and germline risk factors for multiple treatmentrelated toxicities in pediatric acute lymphoblastic leukemia"],"prefix":"10.3324","volume":"111","author":[{"given":"Marion K.","family":"Mateos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Mayoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale M.","family":"Barbaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.J.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie E.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Draga","family":"Barbaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Alvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Conyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Catchpoole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi S.","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Dalla-Pozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby N.","family":"Trahair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"88306","doi-asserted-by":"crossref","unstructured":"Mateos MK, Tulstrup M, Quinn MC. Genome-wide association meta-analysis of single-nucleotide polymorphisms and symptomatic venous thromboembolism during therapy for acute lymphoblastic leukemia and lymphoma in Caucasian children. Cancers (Basel). 2020; 12(5):1285.","DOI":"10.3390\/cancers12051285"},{"key":"88307","doi-asserted-by":"crossref","unstructured":"Mateos MK, Marshall GM, Barbaro PM. Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia. Haematologica. 2022; 107(3):635-643.","DOI":"10.3324\/haematol.2020.268565"},{"key":"88308","doi-asserted-by":"crossref","unstructured":"Yeoh A, Collins A, Fox K. Treatment delay and the risk of relapse in pediatric acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2017; 34(1):38-42.","DOI":"10.1080\/08880018.2016.1276235"},{"key":"88309","doi-asserted-by":"crossref","unstructured":"te Winkel ML, Pieters R, Hop WC. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2011; 29(31):4143-4150.","DOI":"10.1200\/JCO.2011.37.3217"},{"key":"88310","doi-asserted-by":"crossref","unstructured":"Kawedia JD, Kaste SC, Pei D. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011; 117(8):2340-2347.","DOI":"10.1182\/blood-2010-10-311969"},{"key":"88311","doi-asserted-by":"crossref","unstructured":"Bhojwani D, Sabin ND, Pei D. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol. 2014; 32(9):949-959.","DOI":"10.1200\/JCO.2013.53.0808"},{"key":"88312","doi-asserted-by":"crossref","unstructured":"Grace RF, Dahlberg SE, Neuberg D. The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. Br J Haematol. 2011; 152(4):452-459.","DOI":"10.1111\/j.1365-2141.2010.08524.x"},{"key":"88313","doi-asserted-by":"crossref","unstructured":"Tuckuviene R, Ranta S, Albertsen BK. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study. J Thromb Haemost. 2016; 14(3):485-494.","DOI":"10.1111\/jth.13236"},{"key":"88314","doi-asserted-by":"crossref","unstructured":"Diouf B, Crews KR, Lew G. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. JAMA. 2015; 313(8):815-823.","DOI":"10.1001\/jama.2015.0894"},{"key":"88315","doi-asserted-by":"crossref","unstructured":"Reiss SN, Buie LW, Adel N, Goldman DA, Devlin SM, Douer D. Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia. Ann Hematol. 2016; 95(12):2009-2015.","DOI":"10.1007\/s00277-016-2795-7"},{"key":"88316","doi-asserted-by":"crossref","unstructured":"Mateos MK, Trahair TN, Mayoh C. Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia. Thromb Res. 2019; 178:132-138.","DOI":"10.1016\/j.thromres.2019.04.011"},{"key":"88317","doi-asserted-by":"crossref","unstructured":"Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochim Biophys Acta Rev Cancer. 2021; 1875(2):188503.","DOI":"10.1016\/j.bbcan.2021.188503"},{"key":"88318","doi-asserted-by":"crossref","unstructured":"Sullivan PJ, Gayevskiy V, Davis RL. Introme accurately predicts the impact of coding and noncoding variants on gene splicing, with clinical applications. Genome Biol. 2023; 24(1):118.","DOI":"10.1186\/s13059-023-02936-7"},{"key":"88319","doi-asserted-by":"crossref","unstructured":"Miller TP, Getz KD, Li Y. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children\u2019s Oncology Group. Lancet Haematol. 2022; 9(9):e678-e688.","DOI":"10.1016\/S2352-3026(22)00168-5"},{"key":"88320","doi-asserted-by":"crossref","unstructured":"Hodder A, Mishra AK, Enshaei A. Blinatumomab for first-line treatment of children and young persons with B-ALL. J Clin Oncol. 2024; 42(8):907-914.","DOI":"10.1200\/JCO.23.01392"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/12969\/79026","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12969\/79889","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12969\/79026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:10:07Z","timestamp":1794046207000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/12969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2025.288939","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,30]]}}}